A new antibiotic, aplasmomycin, which inhibits growth of Gram-positive bacteria including mycobacteria in vitro, and plasmodia in vivo was obtained from a strain of Streptomyces griseus isolated from shallow sea sediment in Sagami Bay. The antibiotic forms colorless needle-like crystals and has a molecular formula of C41H60O14Na. Based on its physical and chemical properties, aplasmomycin was concluded to be a new antibiotic. The antibiotic was produced in selected media devised to relate to a marine environment.
As shown in a previous paper", it is expected that marine Actinomycetales may represent a good source of new metabolites. In the course of screening for antibiotics produced only in specially devised media relating to marine environments, an Actinomycetales produced a new antimicrobial product, SS-228 Y2,3) having inhibitory activities against tumors and dopamine /3-hydroxylase as well.
In this paper, another new antibiotic, aplasmomycin, will be described including taxonomy of its producer, cultural conditions for production of aplasmomycin, and isolation and properties of the active principle. Cultural characteristics on various agar media Table 1 shows the cultural characteristics of strain SS-20 on various media suggested by SHIRLING and GOTTLIEB4) or by WAKSMAN5), with addition of media that had been used for isolation of marine Actinomycetales2 .
Identification of the
Color designations are those of the Japan Color Standard6 and Color Harmony Manual').
Physiological properties
Utilization of carbon sources was examined by using the PRIDHAM-GOTTLIEB basal medium (ISP.
Med. No. 9). The results are shown in Table 2 . Other physiological characteristics are described in 
Production of Aplasmomycin
A wide variety of media was examined to define reproducible and suitable conditions for production of aplasmomycin by strain SS-20. Because this strain was isolated from marine sediment which is poor in nutrients and fairly high in salt concentration, the effect of NaCI and nutrient concentrations on the production of aplasmomycin was studied in basal medium YE broth, containing yeast extract 0.4%, malt extract 1.0% and glucose 0.4%, pH 7.4. When strain SS-20 was shake-cultured in YE broth, it did not produce aplasmomycin. However, it did produce the antibiotic in a medium with diluted nutrients and high salt concentration. The maximum yield (50 mcg/ml) of aplasmomycin was obtained in dilYE medium where basal medium YE was diluted to 1/16 with deionized water supplemented with 3.0% NaCI, as shown in Table 4 .
Because Kobu-Cha medium containing the powdered tangled sea weed, Laminaria sp., as nutrient source was successful for the culture of marine Actinomycetales as described in the previous paper 2), the production of aplasmomycin in Kobu-Cha medium was examined. Table 5 shows the effect of NaCI on aplasmomycin production by strain SS-20 in medium containing Kobu-Cha* 1.0%, glucose 1.0%, pH 7.8 before sterilization. Maximum production (125 mcg/ml) was obtained on supplementation with 1.5 % NaCl. After a survey of media in 500-m1 SAKACUCIHI flasks for antibiotic production, a medium containing Kobu-Cha 1.0%, glucose 1.0 %, NaCI 1.5 %, pH 7.8 was found to be suitable. Spores of strain SS-20 cultivated on an agar slant of SC (soluble starch 1.0%, casein 0.1 %, agar 1.7%, artificial sea water 500 ml+dist. water 500 ml, pH 7.4, before sterilization) medium at 27°C for 2~3 weeks were inoculated into 125 ml of liquid medium in a 500-m1 flask and shaken on a reciprocal shaker with 8-cm amplitude, 130 strokes per minute at 27°C for 72 hours. Twenty ml of this broth were transferred to 1,250 ml of the same medium in a flask and shake-cultured as above for 120 hours. Anti-* Fuji Shokuhin Co ., Osaka, Japan The medium (10 ml) was incubated in test tube ** less than 5 mcg/ml aplasmomycin (18 x 150 mm) on a shaker (1.8-cm amplitude, 228 The medium (10 ml) was incubated in test tubes strokes/min) at 27°C for 5 days . (18 x 150 mm) on a shaker (1.8-cm amplitude, 288 strokes/min) at 27°C for 5 days. biotic production was determined by a cylinder-plate microbiological assay using Staphylococcus aureus FDA 209P as the test organism. The maximum yield obtained was 60 mcg/ml at 120-hour incubation.
Isolation and Purification
The fermented broth (pH 6.5) was adjusted to pH 5.0 with dilute hydrochloric acid and filtered to remove the mycelium. The mycelium does not contain much of the antibiotics. Twenty liters of filtrate containing 5060 mcg of aplasmomycin per ml were extracted with 10 liters of butyl acetate.
The solvent layer was concentrated in vacuo at 40°C to give a yellowish colored syrup of aplasmomycin (420 mg). The syrup was placed on the top of column (1.5 X 20 cm) filled with 30 g of alumina (neutral, Woelm).
The charged column was developed with n-hexane and ethyl acetate (9:1) and the eluted fractions having antimicrobial activity were collected. The combined fraction was concentrated in vacuo at 40°C to give a pale yellowish powder (230 mg), which was 90 % purified aplasmomycin. The powder was could be explained as a trace ion of K-containing aplasmomycin. As shown in Fig. 1 , its infrared absorption spectrum shows a carbonyl band at 1740 cm -1 and no carboxylate band at 1600 cm -1 region. The pmr spectrum of aplasmomycin (CDCl3) is shown in Fig. 2 Biological Activity
As shown in Table 6 , aplasmomycin inhibits Gram-positive bacteria including mycobacteria in vitro on the media indicated. Groups of 5 male mice of 4 weeks age were infected intraperitoneally by Plasmodium berghei (NK 65). In the control infected group, 3 of 5 mice died within 8 days and plasmodia were observed in more than half of the red cells in the 2 surviving mice. When aplasmomycin in peanut-oil (homogenized using glass beads) was administered orally in 2 doses of 100 mg/kg each by sonde, it decreased the number of plasmodium-containing red cells and all treated mice survived.
Details of these experiments and results as well as other biological activities will be presented separately. The acute toxicity (LD50) in mice was 125 mg/kg by intraperitoneal injection.
Discussion
Two-hundred strains of marine Actinomycetales, which showed no antimicrobial activity when shake-cultured in ordinary media such as YE (yeast extract 0.4 %, malt extract 1.0% and glucose 0.4 %, pH 7.4) and PS (soluble starch 3.0%, Pharmamedia 1.5%, cornsteep liquor 2.0%, beef extract 1.0 %, pH 7.4) were selected. Among these 200 strains, 7 showed antimicrobial activity against test microorganisms when they were cultured in dilYE or Kobu-Cha media. When strain SS-20 was shake-cultured in dilYE and Kobu-Cha media, it produced aplasmomycin. It is of especial interest that this strain produces aplasmomycin favorably in dilYE broth which is prepared by diluting YE medium to 1/16 with water and supplemented with 3.0% NaCl. Aplasmomycin appears to belong to an ionophore antibiotic group based on its physicochemical properties. The it spectrum, however, showed no carboxylate band and it differs from other polyether antibiotics hitherto reported, such as nigericin and monensins8'. Some polyether antibiotics have been reported to be inhibitory to coccidia of chickens but not to plasmodia. A few, such as septamycine9) and 31,559 RP10' were found to be active against plasmodia, and they seem to be considerably toxic to animals (the former: 5 mg/kg i.v. in dogs, 10-30 mg/kg orally in rats, the latter: 150 mg/kg orally in chickens). In this regard, aplasmomycin is less toxic to animals than those above, and administration of multiple large doses is promising. Aplasmomycin is somewhat similar to macrotetrolide group antibiotics such as nonactin'1 but physicochemical properties of aplasmomycin differ from all the members in that group. The absolute structure by X-ray crystallography will be described by Y. IITAKA of Tokyo University in a separate paper. The structure contains methane tetroxy carbon (_O>C<O_) and appears to represent the first discovery of this structural feature in nature.
